Medical Laboratories - Companies & Stock Screener

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

YoY Change

Natera Inc

NTRA

Market Cap $33.14B

Dividends 0.0%

P/E Ratio -144.7

Revenue $697M +38.8%

Net Income -$85.1M +27.1%

Profit Margin -12.2%

View Stock

West Pharmaceutical Services, Inc.

WST

Market Cap $23.17B

Dividends 0.3%

P/E Ratio 43.5

Revenue $845M +21.0%

Net Income $139M +54.6%

Profit Margin +16.4%

View Stock

Celcuity Inc

CELC

Market Cap $4.28B

Dividends 0.0%

P/E Ratio -22.6

Revenue $0.00

Net Income -$52.8M +42.8%

Profit Margin

View Stock

Veracyte Inc

VCYT

Market Cap $4.28B

Dividends 0.0%

P/E Ratio 48.5

Revenue $139M +21.5%

Net Income $28.7M +307.4%

Profit Margin +20.6%

View Stock

Viridian Therapeutics Inc

VRDN

Market Cap $1.5B

Dividends 0.0%

P/E Ratio -4.7

Revenue $141k +95.8%

Net Income -$105M +20.7%

Profit Margin -74397.9%

Employees 27

View Stock

Caredx Inc

CDNA

Market Cap $1.35B

Dividends 0.0%

P/E Ratio -165.6

Revenue $118M +39.0%

Net Income $2.81M -127.1%

Profit Margin +2.4%

View Stock

Personalis Inc

PSNL

Market Cap $936M

Dividends 0.0%

P/E Ratio -11.5

Revenue $0.00 -100.0%

Net Income -$30M +90.7%

Profit Margin

View Stock

Opgen Inc

OPGN

Market Cap $242.67M

Dividends 0.0%

P/E Ratio 1.5

Revenue $0.00

Net Income -$711k +74.1%

Profit Margin

View Stock

Genetron Holdings Ltd - ADR

GTH

Market Cap $127.29M

Dividends 0.0%

P/E Ratio -1.0

Revenue $201M

Net Income -$199M

Profit Margin -99.1%

View Stock

AnPac Bio-Medical Science Co Ltd - ADR

ANPC

Market Cap $26.97M

Dividends 0.0%

P/E Ratio -0.5

Revenue $437k

Net Income -$32.3M

Profit Margin -7394.3%

View Stock

Progenity Inc

PROG

Market Cap $8.18M

Dividends 0.0%

P/E Ratio 0.0

Revenue $32k

Net Income -$18.4M -74.9%

Profit Margin -57506.3%

View Stock

Invitae Corp

NVTA

Market Cap $5.44M

Dividends 0.0%

P/E Ratio 0.0

Revenue $121M -9.2%

Net Income -$942M +212.8%

Profit Margin -777.1%

View Stock

Fresh2 Group Ltd - ADR

FRES

Market Cap $2.08M

Dividends 0.0%

P/E Ratio 0.0

Revenue $619k

Net Income -$4.42M

Profit Margin -714.8%

Employees 89

View Stock

Biora Therapeutics Inc

BIOR

Market Cap $994.99K

Dividends 0.0%

P/E Ratio 0.0

Revenue $32k

Net Income -$18.4M -74.9%

Profit Margin -57506.3%

Employees 642

View Stock

Vyant Bio Inc

VYNT

Market Cap $0

Dividends 0.0%

P/E Ratio -0.1

Revenue $46k

Net Income -$10.3M

Profit Margin -22417.4%

Employees 40

View Stock

Cancer Genetics Inc.

CGIX

Market Cap $

Dividends

P/E Ratio 0.0

Revenue $5.75M

Net Income -$8M

Profit Margin -139.1%

View Stock